S. García‐Garzón

450 total citations
15 papers, 350 citations indexed

About

S. García‐Garzón is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, S. García‐Garzón has authored 15 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hepatology, 7 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in S. García‐Garzón's work include Hepatitis C virus research (9 papers), Hepatitis B Virus Studies (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). S. García‐Garzón is often cited by papers focused on Hepatitis C virus research (9 papers), Hepatitis B Virus Studies (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). S. García‐Garzón collaborates with scholars based in Spain, Mexico and Türkiye. S. García‐Garzón's co-authors include J.R. Larrubia, E. Sanz‐de‐Villalobos, Ana Moreno, Selma Benito‐Martínez, Rafael Bárcena, Miryam Calvino, Cristian Perna, Martín J. García‐González, Trinidad Parra and Alejandro González‐Praetorius and has published in prestigious journals such as Journal of Hepatology, American Journal of Transplantation and World Journal of Gastroenterology.

In The Last Decade

S. García‐Garzón

14 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. García‐Garzón Spain 11 250 210 82 35 35 15 350
Seizaburo Kashiwagi Japan 11 262 1.0× 267 1.3× 39 0.5× 14 0.4× 18 0.5× 26 397
Ernest Song South Africa 9 209 0.8× 240 1.1× 39 0.5× 22 0.6× 6 0.2× 16 339
Paula G. Smith United States 10 336 1.3× 366 1.7× 27 0.3× 13 0.4× 13 0.4× 11 428
G. Davis United States 7 187 0.7× 143 0.7× 41 0.5× 8 0.2× 46 1.3× 11 240
Yoshitaka Etoh Japan 11 368 1.5× 308 1.5× 27 0.3× 7 0.2× 30 0.9× 19 422
P. Pensati Italy 8 315 1.3× 268 1.3× 18 0.2× 7 0.2× 65 1.9× 15 378
T Sodeyama Japan 10 464 1.9× 439 2.1× 17 0.2× 22 0.6× 31 0.9× 19 536
Arthur Kim United States 8 96 0.4× 106 0.5× 77 0.9× 21 0.6× 7 0.2× 10 251
A.B. van Nunen Netherlands 11 477 1.9× 545 2.6× 36 0.4× 5 0.1× 13 0.4× 18 619
Hendrik Luxenburger Germany 8 172 0.7× 214 1.0× 116 1.4× 23 0.7× 4 0.1× 15 369

Countries citing papers authored by S. García‐Garzón

Since Specialization
Citations

This map shows the geographic impact of S. García‐Garzón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. García‐Garzón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. García‐Garzón more than expected).

Fields of papers citing papers by S. García‐Garzón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. García‐Garzón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. García‐Garzón. The network helps show where S. García‐Garzón may publish in the future.

Co-authorship network of co-authors of S. García‐Garzón

This figure shows the co-authorship network connecting the top 25 collaborators of S. García‐Garzón. A scholar is included among the top collaborators of S. García‐Garzón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. García‐Garzón. S. García‐Garzón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
3.
Larrubia, J.R., Selma Benito‐Martínez, Miryam Calvino, et al.. (2011). Bim-mediated apoptosis and PD-1/PD-L1 pathway impair reactivity of PD1+/CD127− HCV-specific CD8+ cells targeting the virus in chronic hepatitis C virus infection. Cellular Immunology. 269(2). 104–114. 34 indexed citations
4.
5.
Bermejo, Fernando, Antonio López-San Román, Alicia Algaba, et al.. (2010). Factors that modify therapy adherence in patients with inflammatory bowel disease. Journal of Crohn s and Colitis. 4(4). 422–426. 30 indexed citations
6.
Guerra, Iván, Luís Rábago, Fernando Bermejo, E Quintanilla, & S. García‐Garzón. (2009). Ectopic papilla of Vater in the pylorus. World Journal of Gastroenterology. 15(41). 5221–5221. 13 indexed citations
7.
Bermejo, Fernando, Alicia Algaba, Javier P. Gisbert, et al.. (2009). Mercaptopurine rescue after azathioprine‐induced liver injury in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 31(1). 120–124. 11 indexed citations
8.
Carneros, J.A., Bélen Piqueras, Fernando Bermejo, et al.. (2009). Pancreatitis aguda y lesiones ocupantes de espacio hepáticas en paciente trasplantado de médula ósea por mieloma múltiple. Gastroenterología y Hepatología. 32(6). 410–414.
9.
Bermejo, Fernando, Alicia Algaba, J.A. Carneros, et al.. (2009). ¿QUÉ FACTORES INFLUYEN EN LA ADHESIÓN AL TRATAMIENTO EN LA ENFERMEDAD INFLAMATORIA INTESTINAL?. Gastroenterología y Hepatología. 32(3). 224–224. 1 indexed citations
10.
Calvino, Miryam, et al.. (2007). [447] ROLE OF CCR5 AND CXCR3 CHEMOKINE RECEPTORS EXPRESSION ON CD8+ CELLS DURING CHRONIC HEPATITIS C INFECTION. Journal of Hepatology. 46. S170–S170. 1 indexed citations
11.
Larrubia, J.R., Miryam Calvino, Selma Benito‐Martínez, et al.. (2007). The role of CCR5/CXCR3 expressing CD8+ cells in liver damage and viral control during persistent hepatitis C virus infection. Journal of Hepatology. 47(5). 632–641. 79 indexed citations
12.
Moreno, Ana, Rafael Bárcena, S. García‐Garzón, et al.. (2006). Viral kinetics and early prediction of nonresponse to peg‐IFN‐α‐2b plus ribavirin in HCV genotypes 1/4 according to HIV serostatus*. Journal of Viral Hepatitis. 13(7). 466–473. 12 indexed citations
13.
Bárcena, Rafael, J.M. Moreno Planas, Valentín Cuervas‐Mons, et al.. (2006). Hepatitis C Recurrence After Liver Transplantation: Viral and Histologic Response to Full-Dose Peg-Interferon and Ribavirin. American Journal of Transplantation. 6(10). 2348–2355. 88 indexed citations
14.
Moreno, Ana, Ana Moreno, Rafael Bárcena, et al.. (2005). HCV clearance and treatment outcome in genotype 1 HCV-monoinfected, HIV-coinfected and liver transplanted patients on peg-IFN-α-2b/ribavirin. Journal of Hepatology. 43(5). 783–790. 22 indexed citations
15.
Bárcena, Rafael, S. García‐Garzón, Ana Moreno, et al.. (2005). Pegylated Interferon and Ribavirin for the Recurrence of Chronic Hepatitis C Genotype 1 in Transplant Patients. Transplantation Proceedings. 37(9). 3963–3964. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seizaburo Kashiwagi Breakdown of academic impact, for papers by Ernest Song Breakdown of academic impact, for papers by Paula G. Smith Breakdown of academic impact, for papers by G. Davis Breakdown of academic impact, for papers by Yoshitaka Etoh Breakdown of academic impact, for papers by P. Pensati Breakdown of academic impact, for papers by T Sodeyama Breakdown of academic impact, for papers by Arthur Kim Breakdown of academic impact, for papers by A.B. van Nunen Breakdown of academic impact, for papers by Hendrik Luxenburger
Rankless by CCL
2026